Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

arthralgia/сарком

Веза се чува у привремену меморију
ЧланциКлиничка испитивањаПатенти
Страна 1 од 19 резултати

A case of spindle cell dominant histiocytic sarcoma showing a complete remission after first-line chemotherapy with doxorubicin and ifosfamide

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Histiocytic sarcoma (HS), an extremely rare malignancy, usually follows a progressive time course, and patients die within two years of diagnosis. At present, there is no consensus for effective chemotherapy.We report the case of a 54-year-old man who presented with low back pain and left hip joint

Therapeutic trial of interferon-gamma in patients with epidemic Kaposi's sarcoma.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
An epidemic form of Kaposi's sarcoma associated with the acquired immune deficiency syndrome has been recently described. Seven homosexual men with biopsy-documented epidemic Kaposi's sarcoma were treated with a human interferon-gamma preparation. All patients had generalized disease. Only one

Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Tumor necrosis factor (TNF) has demonstrated antitumor activity against a variety of tumors and is particularly cytotoxic to capillary endothelial cells, which are the presumed cell of origin of Kaposi's sarcoma. We evaluated the toxicity and clinical antitumor and antiretroviral effects of

[Physiotherapy in early rehabilitation of patients with bone sarcomas after arthroplasty of large bones and joints]

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Actuality: The modern method of treating patients with tumor lesions of the bones is the replacement of large bones and joints with the inclusion of reconstructive plastic component. The main functional postoperative disorders of this

[Acute myelocytic leukemia (M0) in an elderly patient with relapsed granulocytic sarcoma (M7) of bone during the second period of complete remission 5 years after onset].

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
A 75-year-old man was admitted because of right knee joint pain in December 1999. He had suffered from acute myelocytic leukemia (AML: M0) in November 1994 and achieved the first complete remission (CR) then. His AML relapsed in August 1996, but fortunately he achieved a second CR. Radiographical

Paraneoplastic autoimmunity associated with testicular myeloid sarcoma and chronic myelomonocytic leukemia.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Myeloid sarcomas are rare extramedullary solid tumors composed of immature myeloid cells. The clinical presentations of these malignant neoplasms are highly variable, ranging from asymptomatic to localized mass effect. Here, we report an unusual case of myeloid sarcoma of the testis found in

Synovial sarcoma: clinicopathologic features, treatment, and prognosis.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Synovial sarcoma is a characteristic subtype of soft tissue sarcomas with a predilection for young people. There may be a long delay in diagnosis or misdiagnosis, because of its insidious growth, varied presentation on imaging studies and associated joint pain, which can be confused with trauma.

Multiple granulocytic sarcomas in essential thrombocythemia.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
A 59-year-old woman was diagnosed with essential thrombocythemia in 1988 and had been treated with hydroxyurea, mitobronitol, busulfan, and ranimustine, in that order. Hepatosplenomegaly, low-grade fever, and body weight loss manifested, and a few blasts were noted in the peripheral blood studied in

[Malignant disease presenting as rheumatic manifestations].

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND Musculoskeletal pain is a frequent complaint in pediatrics in both tertiary and primary care. Although musculoskeletal symptoms are not usually related to severe disease, they can represent the first manifestation of an occult malignancy. OBJECTIVE To describe the clinical manifestations

Diagnosis of malignancies in children with musculoskeletal complaints.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND Musculoskeletal complaints may be associated with neoplasias as an initial manifestation of the disease. When these symptoms predominate at the onset of the disease, the differential diagnosis includes several rheumatic diseases. OBJECTIVE To assess the frequency, clinical features and

Pharmacological effects of novel cross-linked hyaluronate, Gel-200, in experimental animal models of osteoarthritis and human cell lines.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE To study the pharmacological effects of Gel-200, cross-linked hyaluronate. METHODS We examined the chondroprotective, anti-inflammatory and analgesic effects of Gel-200 in experimental animal models for osteoarthritis (OA) and in a human synovial sarcoma cell line and normal human

Primary neoplasms of the heart. Clinical and histological presentation of 50 cases.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE To analyze clinical and histologic findings of 50 patients with primary neoplasms of the heart in a tertiary referral center. METHODS From 1980 to 1998, we retrospectively analyzed 50 patients, 32 of whom were females, whose ages ranged from 9 to 73 years (mean age = 44.16+/-18

Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumors.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE STA-4783 is a new compound that markedly enhances the therapeutic index of paclitaxel against human tumor xenograft models. A phase I clinical trial was undertaken to determine the maximum tolerated dose, toxicity profile, and pharmacokinetics of STA-4783 in combination with

Ixabepilone: a novel microtubule inhibitor for the treatment of locally advanced or metastatic breast cancer.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND Ixabepilone is the first member of the epothilones, a new class of anticancer drugs. It is approved for use as monotherapy in patients with locally advanced or metastatic breast cancer that has failed to respond to therapy with a taxane, an anthracycline, and capecitabine, or in

LXR modulation blocks prostaglandin E2 production and matrix degradation in cartilage and alleviates pain in a rat osteoarthritis model.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Osteoarthritis (OA), the most common arthritic condition in humans, is characterized by the progressive degeneration of articular cartilage accompanied by chronic joint pain. Inflammatory mediators, such as cytokines and prostaglandin E(2) (PGE(2)) that are elevated in OA joints, play important
Придружите се нашој
facebook страници

Најкомплетнија база лековитог биља подржана науком

  • Ради на 55 језика
  • Биљни лекови потпомогнути науком
  • Препознавање биљака по слици
  • Интерактивна ГПС мапа - означите биље на локацији (ускоро)
  • Читајте научне публикације повезане са вашом претрагом
  • Претражите лековито биље по њиховим ефектима
  • Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима

Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима

Google Play badgeApp Store badge